跳至主要内容
临床试验/NCT00858481
NCT00858481已完成2 期

Efficacy and Safety of Different Strengths of Spinosad Topical Creme (0%, 0.5%, 1.0% or 2%) in Subjects With Pediculosis Capitis - a Dose Ranging Study

ParaPRO LLC1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2005年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
ParaPRO LLC
入组人数
36
试验地点
1
主要终点
Efficacy of various doses of Spinosad, based on the presence or absence of live lice at 7 and 14 days post-treatment. The efficacy evaluation was performed by a trained evaluator.

研究概览

简要总结

A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.

详细描述

A Phase 2a, randomized, single investigational site, investigator/evaluator-blind, four-arm, parallel-group, vehicle-controlled, pilot study to evaluate the safety and efficacy of different strengths of Spinosad Creme rinse verses vehicle control.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
2 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Active head lice infestation
  • Male or female, 2 years of age or older
  • Good general health
  • Appropriately signed Informed Consent
  • Subject agreement to not use any other form of lice treatment during the course of the study
  • Subject agreement to not cut or chemically treat their hair between visits

排除标准

  • History of irritation or sensitivity to pediculicides or hair care products
  • Individuals with any visible skin/scalp condition that would interfere with the evaluation
  • Individuals previously treated with a pediculicide within 4 weeks prior to study enrollment
  • Individuals using hair dyes, bleaches, permanent waves or relaxing solutions 2 weeks prior to study enrollment
  • Individuals who have participated in any clinical trial within 30 days of enrollment
  • Individuals with family members who were infested with lice but were unwilling or unable to enroll in the study or use a standard course of lice treatment
  • Females who were pregnant or nursing
  • Sexually active females not using effective contraception

研究组 & 干预措施

1

Placebo Comparator

Vehicle control

干预措施: Spinosad Creme Rinse - Vehicle Control (Drug)

2

Active Comparator

0.5% Spinosad creme rinse

干预措施: Spinosad Creme Rinse (Drug)

3

Active Comparator

1.0% Spinosad Creme Rinse

干预措施: Spinosad Creme Rinse (Drug)

4

Active Comparator

2.0% Spinosad Creme Rinse

干预措施: Spinosad Creme Rinse (Drug)

结局指标

主要结局

Efficacy of various doses of Spinosad, based on the presence or absence of live lice at 7 and 14 days post-treatment. The efficacy evaluation was performed by a trained evaluator.

时间窗: 14 days

次要结局

  • Safety of various doses of Spinosad, based on the occurrence of adverse events, especially scalp irritation.(14 days)

研究者

发起方
ParaPRO LLC
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验